Hetal Pandya

发表

Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.

W. Debinski, Hetal Pandya, 2012, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Toward Intracellular Targeted Delivery of Cancer Therapeutics

W. Debinski, Hetal Pandya, 2012, BioDrugs.

Molecular targeting of intracellular compartments specifically in cancer cells.

W. Debinski, D. Gibo, Hetal Pandya, 2010, Genes & cancer.

Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.

E. Tramontano, A. Geronikaki, P. Eleftheriou, 2019, European journal of medicinal chemistry.

An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts.

S. Kridel, W. Debinski, D. Gibo, 2012, Neuro-oncology.

Differentiation of human and murine induced pluripotent stem cells to microglia-like cells

D. Maric, D. McGavern, John K. Park, 2017, Nature Neuroscience.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Novel molecular multilevel targeted antitumor agents

W. Debinski, W. Priebe, I. Fokt, 2017, Cancer translational medicine.

Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1.

Nicholette D. Palmer, J. L. Bento, C. Langefeld, 2008, Genomics.

An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts.

S. Kridel, W. Debinski, D. Gibo, 2012, Neuro-oncology.